HHS Clarifies that FDA Cannot Regulate LDTs
The Department of Health and Human Services (HHS), the governing body over the FDA, rescinded FDA’s guidance documents regarding the need for pre-market approval or emergency use authorization for Laboratory Developed diagnostic tests (LDTs). LDTs are widely used and have been in a regulatory limbo for many years because of contradictory FDA announcements. FDA has … Read more